# Atazanavir for HIV Infected Individuals: An Early Access Program

> **NCT00046345** · — · NO_LONGER_AVAILABLE · sponsor: **Bristol-Myers Squibb**

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Atazanavir (BMS-232632)

## Key facts

- **NCT ID:** NCT00046345
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** 2002-05
- **Primary completion:** —
- **Final completion:** 2003-07
- **Target enrollment:** — (—)
- **Last updated:** 2011-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00046345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00046345, "Atazanavir for HIV Infected Individuals: An Early Access Program". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00046345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*